Related Experiment Videos
[Role of NK cells in lung metastasis immunosurveillance]
1Basic Medical Sciences Division, National Institute for Environmental Studies.
Abstract:
NK cells play an important role in fighting tumor metastases. The incidence of metastasis was found to increase in mice with low cytotoxicity of NK cells. In the mice with high cytotoxicity of NK cells, the incidence of metastasis decreased. LAK cells induced by IL2 mediate the regression of established metastases from a variety of tumors. LAK progenitor cells were predominantly found in CD3-CD16+ Leu19+ fraction, a subset that are known to be the NK cells. Thus, NK cell lineage in LAK cells plays an important role for the inhibition of tumor metastases. Cells having NK cell-like phenotype nature, however, also play a key role in the side effects of adoptive immunotherapy involving IL2. In order to decrease adverse side effects during therapy, we are currently testing combination therapy of LAK cells plus IL2, IL2 alone with IFN, TNF, BRM, indomethacin and so on. Overall, augmentation of NK cells is one of the significant therapeutic methods to prevent metastases.
Insights
Augmenting natural killer (NK) cells enhances their tumor-fighting ability, reducing cancer metastasis. This research highlights NK cells
Area of Science:
- Immunology and Cancer Research: Focuses on the role of immune cells in cancer progression and treatment.
Context:
- Tumor metastasis is a significant challenge in cancer treatment, often associated with reduced immune surveillance.
- Natural Killer (NK) cells are critical immune components involved in recognizing and eliminating tumor cells.
- Interleukin-2 (IL2)-induced Lymphokine-Activated Killer (LAK) cells, derived from NK cell progenitors, demonstrate anti-metastatic effects.
Purpose:
- To investigate the correlation between NK cell cytotoxicity and the incidence of tumor metastasis.
- To elucidate the role of NK cell lineage within LAK cells in inhibiting tumor metastases.
- To explore strategies for mitigating side effects associated with IL2-based immunotherapy.
Summary:
- Studies indicate that higher NK cell cytotoxicity correlates with decreased metastasis, while lower cytotoxicity is linked to increased metastasis.
- LAK cells, particularly those originating from the CD3-CD16+ Leu19+ NK cell subset, effectively mediate the regression of established metastases.
- NK cell-like phenotypes contribute to immunotherapy side effects, prompting research into combination therapies (e.g., LAK cells + IL2, IL2 + IFN, TNF, BRM, indomethacin) to reduce adverse events.
Impact:
- Demonstrates that augmenting NK cell activity is a promising therapeutic strategy for preventing and treating cancer metastasis.
- Provides insights into the mechanisms underlying NK cell-mediated anti-tumor immunity.
- Informs the development of safer and more effective adoptive immunotherapy protocols for cancer patients.